Combining a herpes virus genetically altered to express a drug-enhancing enzyme with a chemotherapy drug effectively and safely reduced the size of highly malignant human sarcoma grafted into mice. This new finding may add to the growing arsenal of so called oncolytic viruses under development as novel cancer treatments, especially for difficult, inoperable tumors
…
“Based on these findings and other preclinical studies, we expect oncolytic viral therapy will be one additional treatment modality available in the future for oncologists,” Dr. Cripe said. “The challenge over the next decade will be determining which viruses work best for which cancers, at what doses, schedules, routes of administration, and in what combinations with other treatments.”

A laboratory-engineered virus that can find its way through the vascular system and kill deadly brain tumors has been developed by Yale School of Medicine researchers, it was reported this week in the Journal of Neuroscience.

Each year 200,000 people in the United States are diagnosed with a brain tumor, and metastatic tumors and glioblastomas make up a large part of these tumors. There currently is no cure for these types of tumors, and they generally result in death within months.
…
“Three days after inoculation, the tumors were completely or almost completely infected with the virus and the tumor cells were dying or dead,” van den Pol said. “We were able to target different types of cancer cells. Within the same time frame, normal mouse brain cells or normal human brain cells transplanted into mice were spared. This underlines the virus’ potential therapeutic value against multiple types of brain cancers.”

Manufacturing was once the province of human hands, then of machines. Angela Belcher, professor of materials science and engineering and biological engineering at MIT, has pushed manufacturing in another, much smaller, direction: Her lab has genetically engineered viruses that can construct useful objects like electrodes and wires.
…
Her lab employed this method to form an electrode that can be used in a lithium ion battery like the rechargeable ones used in electronics. The result looks like an innocuous length of celluloid tape, the sort you could use to wrap a package.

“It’s self-assembled,” says Belcher. “The viruses make these materials at room temperature.” So there’s little pollution.
…
Belcher hopes to be making prototypes within the next two years. “Actual devices are five to 10 years off.”